Skip to main content
SpringerLink
Log in

Pemphigoid nodularis associated with pembrolizumab in a lung cancer patient

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Juzot C, Sibaud V, Amatore F, et al. Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: a national retrospective study. J Eur Acad Dermatol Venereol 2021; 35: e511–14.

    Article  CAS  PubMed  Google Scholar 

  2. Tsiogka A, Bauer JW, Patsatsi A. Bullous pemphigoid associated with anti-programmed cell death protein 1 and anti-programmed cell death ligand 1 therapy: a review of the literature. Acta Derm Venereol 2021; 101: adv00377.

    Article  CAS  PubMed  Google Scholar 

  3. Asdourian MS, Shah N, Jacoby TV, Reynolds KL, Chen ST. Association of bullous pemphigoid with immune checkpoint inhibitor therapy in patients with cancer: a systematic review. JAMA Dermatol 2022; 158: 933–41.

    Article  PubMed  Google Scholar 

  4. Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2022; 36: 1689–704.

    Article  CAS  PubMed  Google Scholar 

  5. Lopez AT, Geskin L. A case of nivolumab-induced bullous pemphigoid: review of dermatologic toxicity associated with programmed cell death protein-1/programmed death ligand-1 inhibitors and recommendations for diagnosis and management. Oncologist 2018; 23: 1119–26.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Apalla Z, Lallas A, Delli F, et al. Management of immune checkpoint inhibitor-induced bullous pemphigoid. J Am Acad Dermatol 2021; 84: 540–3.

    Article  CAS  PubMed  Google Scholar 

  7. Fattore D, Panariello L, Annunziata MC, Fabbrocini G. Prurigo nodularis and pembrolizumab: a therapeutic challenge. Eur J Cancer 2019; 110: 8–10.

    Article  PubMed  Google Scholar 

  8. Alonso-Llamazares J, Rogers RS, 3rd, Oursler JR, Calobrisi SD. Bullous pemphigoid presenting as generalized pruritus: observations in six patients. Int J Dermatol 1998; 37: 508–14.

    CAS  PubMed  Google Scholar 

  9. Cliff S, Holden CA. Pemphigoid nodularis: a report of three cases and review of the literature. Br J Dermatol 1997; 136: 398–401.

    Article  CAS  PubMed  Google Scholar 

  10. Yoshimoto N, Ujiie H, Hirata Y, Izumi K, Nishie W, Shimizu H. Bullous pemphigoid developed in a patient with prurigo nodularis. J Eur Acad Dermatol Venereol 2017; 31: e187–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, National Defence Medical College, Tokorozawa, Japan

    Mihiro Yamamoto, Takashi Hashimoto, Manami Okuzawa, Kazuki Yashiki, Satoshi Okuno, Kayo Awatani-Yoshidome, Naomi Akaishi & Takahiro Satoh

Authors
  1. Mihiro Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manami Okuzawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuki Yashiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satoshi Okuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kayo Awatani-Yoshidome
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Naomi Akaishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiro Satoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihiro Yamamoto.

Additional information

Funding sources

none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto, M., Hashimoto, T., Okuzawa, M. et al. Pemphigoid nodularis associated with pembrolizumab in a lung cancer patient. Eur J Dermatol 33, 53–54 (2023). https://doi.org/10.1684/ejd.2023.4418

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2023.4418

Search

Navigation